| 臺大學術典藏 |
2021-01-28T02:02:46Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Kuo-How Huang; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:46Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Chow P.-M.;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Chang H.-C.;Kuo-How Huang; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; Chow P.-M.; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:46Z |
Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients
|
Liu K.-L.;Lee B.-C.;Ye J.-D.;Chang Y.-H.;Chang C.-C.;Kuo-How Huang;Lee Y.-J.;Chang Y.-C.; Liu K.-L.; Lee B.-C.; Ye J.-D.; Chang Y.-H.; Chang C.-C.; KUO-HOW HUANG; Lee Y.-J.; Chang Y.-C. |
| 臺大學術典藏 |
2021-01-28T02:02:47Z |
Is prophylactic nasogastric tube decompression necessary in patients undergoing laparoscopic adrenalectomy for unilateral benign adrenal tumor
|
Chen K.-T.;Wu V.-C.;Wu K.-D.;Kuo-How Huang; Chen K.-T.; Wu V.-C.; Wu K.-D.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:47Z |
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
|
Cheng Y.-T.;Chiang C.-H.;Pu Y.-S.;Liu S.P.;Lu Y.-C.;Chang Y.-K.;Chang H.-C.;Kuo-How Huang;Lee Y.-J.;Chow P.-M.;Hung S.-C.;Huang C.-Y.; Cheng Y.-T.; Chiang C.-H.; Pu Y.-S.; Liu S.P.; Lu Y.-C.; Chang Y.-K.; Chang H.-C.; KUO-HOW HUANG; Lee Y.-J.; Chow P.-M.; Hung S.-C.; Huang C.-Y. |
| 臺大學術典藏 |
2021-01-28T02:02:48Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Kuo-How Huang;Yu C.-C.;Hu Y.-H.;Chang C.-C.;Chan C.-K.;Liao S.-C.;Tsai Y.-C.;Jeff Chueh S.-C.;Wu V.-C.;Lin Y.-H.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Er L.K.;Chang C.-H.;Chang Y.-L.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Lu C.-C.;Yen R.-F.;Wu K.-D.;Taipai, Taiwan Primary Aldosteronism Investigator; KUO-HOW HUANG; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2021-01-28T02:02:48Z |
The influence of the peripheral cortisol fluctuation on the success rate of adrenal venous sampling
|
Chang C.-C.;Lee B.-C.;Liu K.-L.;Chang Y.-C.;Wu V.-C.;Kuo-How Huang;Wu T.-H.; Chang C.-C.; Lee B.-C.; Liu K.-L.; Chang Y.-C.; Wu V.-C.; KUO-HOW HUANG; Wu T.-H. |
| 臺大學術典藏 |
2021-01-28T02:02:49Z |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chan C.-K.;Hu Y.-H.;Chen L.;Chang C.-C.;Lin Y.-F.;Lai T.-S.;Kuo-How Huang;Lin Y.-H.;Wu V.-C.;Wu K.-D.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Chang C.-H.;Chang Y.-L.;Tsai Y.-C.;Yu C.-C.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Wang S.-M.;Liao S.-C.;Lu C.-C.;Yen R.-F.; Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; KUO-HOW HUANG; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F. |
| 臺大學術典藏 |
2021-01-28T02:02:49Z |
Primary aldosteronism and cerebrovascular diseases
|
Chen Z.-W.;Hung C.-S.;Wu V.-C.;Lin Y.-H.;Wu C.-H.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Kuo-How Huang;Chen Y.-M.;Chang C.-C.;Liao S.-C.;Yen R.-F.;Wu K.-D.; Chen Z.-W.; Hung C.-S.; Wu V.-C.; Lin Y.-H.; Wu C.-H.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; KUO-HOW HUANG; Chen Y.-M.; Chang C.-C.; Liao S.-C.; Yen R.-F.; Wu K.-D. |
| 臺大學術典藏 |
2021-01-28T02:02:49Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Kuo-How Huang; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG |
